Cyberonics, Inc. (CYBX) said NYU Langone Medical Center study showed that VNS Therapy is safe and effective treatment for refractory epilepsy.
According to the company, the results showed a more than 50% reduction in seizure frequency occurred in 64.6% of patients and 42.1% of patients experienced more than a 70% reduction in seizure frequency. Patients who had failed intracranial epilepsy procedures prior to VNS Therapy had similar outcomes to those who did not have prior surgery. However, there were no significant differences in efficacy between adults and children.
For comments and feedback contact: editorial@rttnews.com
June 05, 2026 16:18 ET A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.